EVERSANA  to provide integrated commercialization services, enhancing launch readiness and market entry for differentiated ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...

UNSW expert Professor Yansong Shen explains why it is so important to find a way to produce iron and steel in a more ...

The Breeders' Cup will once again offer two distinct live broadcasts, each tailored to deliver the right content on the ...

First and only therapy FDA approved in both R/R acute myeloid leukemia (AML) with an NPM1 mutation and R/R acute leukemia with a KMT2A ...

Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk ...

Complementing NBC Sports' broadcasts, FanDuel TV will present live continuous coverage of every Championship and undercard race through the Breeders' Cup Players' Show, available on FanDuel TV, ...

New 2025 observational research on adults aged 40-65 finds BurnPeak’s Triple-BHB formulation supports measurable fat reduction, energy balance, and appetite control without stimulants.

Discusses Business Transformation Strategy and Plans for Accelerated Growth October 16, 2025 5:00 PM EDTCompany ParticipantsXi-Yong Fu ...

(Head of Commercial: Mike Petroutsas, "Astellas") today announced final overall survival (OS) results from the Phase 3 EMBARK study evaluating XTANDI ® (enzalutamide), in combination with leuprolide ...

Silver prices broke through the USD 53 mark for the first time at the beginning of the week, and gold is attempting to reach ...

Few drinks are so universally popular or so adaptable as a pitcher of iced tea. It’s an enduring essence of uncomplicated ...